Patent details

EP4046994 Title: CHOLINE SALT FORMS OF AN HIV CAPSID INHIBITOR

Basic Information

Publication number:
EP4046994
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP212175533
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CHOLINE SALT FORMS OF AN HIV CAPSID INHIBITOR
French Title of Invention:
FORMES DE SEL D'UN INHIBITEUR DE CAPSIDE HIV
German Title of Invention:
CHOLINSALZFORMEN EINES HIV-CAPSID-INHIBITORS
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
12/03/2024
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
19/03/2024
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
21/02/2024
Unitary Effect Registration Date:
19/03/2024
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
16/08/2018
Grant date:
21/02/2024
EP Publication Date:
24/08/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/02/2024
EP B1 Publication Date:
21/02/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/08/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/02/2024
 
 

Name:
Gilead Sciences, Inc.
Address:
333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
SHI, Bing
Address:
United States (US)

2

Name:
HOUSTON, Travis, Lee
Address:
United States (US)

Priority

Priority Number:
201762546974 P
Priority Date:
17/08/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61P 31/18; C07D 401/14; A61K 31/454;

Publication

European Patent Bulletin

1

Issue number:
202408
Publication date:
21/02/2024
Description:
Grant (B1)

2

Issue number:
202413
Publication date:
27/03/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202416
Publication date:
17/04/2024
Description:
Unitary Effect Request Receipt

4

Issue number:
202416
Publication date:
17/04/2024
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages